Tomin E. Perea-Chamblee

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.

N. Schultz, M. Berger, L. Macconaill, 2022, Cancer cell.

Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation

R. Rabadán, Yiwei Sun, J. Manley, 2020, Proceedings of the National Academy of Sciences.

Pervasiveness of HLA allele-specific expression loss across tumor types

E. López de Maturana, N. Malats, Junfei Zhao, 2023, Genome Medicine.